Authors:
SCHRIJVERS D
PRONK L
HIGHLEY M
BRUNO M
LOCCITONELLI D
DEBRUIJN E
VANOOSTEROM AT
VERWEIJ J
VERMORKEN JB
Citation: D. Schrijvers et al., SEQUENCE-DEPENDENT PHARMACOKINETICS (PK) OF IFOSFAMIDE (I) COMBINED WITH DOCETAXEL (D), European journal of cancer, 34, 1998, pp. 176-176
Authors:
PELGRIMS J
DEVOS F
SCHRIJVERS D
VANDENBRANDE J
PROVE A
VERMORKEN JB
Citation: J. Pelgrims et al., METHYLENE-BLUE (MB) IN THE TREATMENT AND PREVENTION OF IFOSFAMIDE (I)ENCEPHALOPATHY, European journal of cancer, 34, 1998, pp. 191-191
Authors:
SCHRIJVERS D
VANHERPEN C
KERGER J
JOOSENS E
BRANDELY M
VERMORKEN JB
Citation: D. Schrijvers et al., PHASE I-II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND 5-FLUOROURACIL(5-FU) IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN), Annals of oncology, 9, 1998, pp. 359-359
Authors:
HIGHLEY MS
SCHRIJVERS D
ARDIET C
VANOOSTEROM AT
DEBRUIJN EA
Citation: Ms. Highley et al., PHARMACOKINETICS OF THE MITOMYCIN KW-2149 - GENERATION OF THE ACTIVE METABOLITE M-18, Annals of oncology, 9, 1998, pp. 480-480
Authors:
SCHRIJVERS D
JOHNSON J
JIMINEZ U
GORE M
KOSMIDIS P
SZPIRGLAS H
ROBBINS K
OLIVEIRA J
LEWENSOHN R
SCHULLER J
RIVIERE A
ARVAY C
LANGECKER P
JACOB H
CVITKOVIC E
VOKES E
Citation: D. Schrijvers et al., PHASE-III TRIAL OF MODULATION OF CISPLATIN FLUOROURACIL CHEMOTHERAPY BY INTERFERON-ALPHA-2B IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK-CANCER/, Journal of clinical oncology, 16(3), 1998, pp. 1054-1059
Authors:
PRONK LC
SCHRIJVERS D
SCHELLENS JHM
DEBRUIJN EA
PLANTING AST
LOCCITONELLI D
GROULT V
VERWEIJ J
VANOOSTEROM AT
Citation: Lc. Pronk et al., DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS - RESULTS OF A PHASE-I STUDY, Seminars in oncology, 25(1), 1998, pp. 23-28
Authors:
PRONK LC
SCHRIJVERS D
SCHELLENS JHM
DEBRUIJN EA
PLANTING AST
LOCCITONELLI D
GROULT V
VERWEIJ J
VANOOSTEROM AT
Citation: Lc. Pronk et al., PHASE-I STUDY ON DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS, British Journal of Cancer, 77(1), 1998, pp. 153-158
Authors:
VANDENBRANDE J
SCHRIJVERS D
VROMAN P
PROVE A
VANSCHIL P
BECQUART D
VANMARCK E
VANOOSTEROM AT
Citation: J. Vandenbrande et al., LATE RELAPSE OF A NONSEMINOMATOUS GERM-CELL TUMOR FROM RESIDUAL MATURE TERATOMA, Acta Clinica Belgica, 53(3), 1998, pp. 193-197
Authors:
HIGHLEY MS
SCHRIJVERS D
VANOOSTEROM AT
HARPER PG
MOMERENCY G
VANCAUWENBERGHE K
MAES RAA
DEBRUIJN EA
EDELSTEIN MB
Citation: Ms. Highley et al., ACTIVATED OXAZAPHOSPHORINES ARE TRANSPORTED PREDOMINANTLY BY ERYTHROCYTES, Annals of oncology, 8(11), 1997, pp. 1139-1144
Authors:
BOSMANS JL
YSEBAERT D
DECOCK AM
HAUBEN E
MUYLLE L
SCHRIJVERS D
VANMARCK E
EYSKENS E
DEBROE ME
Citation: Jl. Bosmans et al., INTERFERON-ALPHA AND THE CURE OF METASTASIS OF A MALIGNANT MENINGIOMAIN A KIDNEY ALLOGRAFT RECIPIENT - A CASE-REPORT, Transplantation proceedings, 29(1-2), 1997, pp. 838-838
Authors:
BERWAERTS J
VERHELST J
HUBENS H
KUNNEN J
SCHRIJVERS D
JOOSENS E
MAHLER C
VANGAAL L
Citation: J. Berwaerts et al., ROLE OF HEPATIC ARTERIAL EMBOLIZATION IN THE TREATMENT FOR METASTATICINSULINOMA - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE, Acta Clinica Belgica, 52(5), 1997, pp. 263-274
Citation: At. Vanoosterom et D. Schrijvers, RECENT DEVELOPMENTS IN THE BIOLOGY AND MANAGEMENT OF ADVANCED BLADDER-CANCER, European journal of cancer, 31A(5), 1995, pp. 838-839
Citation: At. Vanoosterom et D. Schrijvers, DOCETAXEL (TAXOTERE(R)), A REVIEW OF PRECLINICAL AND CLINICAL-EXPERIENCE .2. CLINICAL-EXPERIENCE (VOL 6, PG 356, 1995), Anti-cancer drugs, 6(4), 1995, pp. 618-618
Authors:
DIRIX LY
VANMEERBEECK J
SCHRIJVERS D
CORTHOUTS B
PROVE A
VANMARCK E
VERMEIRE P
VANOOSTEROM AT
Citation: Ly. Dirix et al., A PHASE-II TRIAL OF DOSE-ESCALATED DOXORUBICIN AND IFOSFAMIDE MESNA IN PATIENTS WITH MALIGNANT MESOTHELIOMA, Annals of oncology, 5(7), 1994, pp. 653-655
Authors:
LEHESRAN JY
DELAPORTE E
GAUDEBOUT C
TREBUCK A
SCHRIJVERS D
JOSSE R
PEETERS M
CHERINGOU H
DUPONT A
LAROUZE B
Citation: Jy. Lehesran et al., DEMOGRAPHIC-FACTORS ASSOCIATED WITH HTLV-1 INFECTION IN A GABONESE COMMUNITY, International journal of epidemiology, 23(4), 1994, pp. 812-817